Hematological Findings among COVID-19 Patients Attending King Khalid Hospital at Najran, Kingdom of Saudi Arabia

COVID-19 is a global pandemic viral infection that has affected millions worldwide. Limited data is available on the effect of COVID-19 on hematological parameters in Saudi Arabia. This study is aimed at examining the role of hematological parameters among COVID-19 patients admitted to King Khalid H...

Full description

Saved in:
Bibliographic Details
Published in:BioMed research international Vol. 2022; no. 1; p. 4620037
Main Authors: Elkhalifa, Ahmed M. E., Elderdery, Abozer Y., Al Bataj, Ibrahim Ali, Tamomh, Abdelhakam G., Alyami, Masaud M., Almakrami, Hussein A., Alofair, Mubarak A., Almorish, Mohammed A., Bashanfer, Salem, Tabash, Mohammed I., Idris, Hadeil M. E., Ahmed, Dania Z., Alhamidi, Abdulaziz H., Mok, Pooi Ling
Format: Journal Article
Language:English
Published: United States Hindawi 2022
John Wiley & Sons, Inc
Subjects:
Adult
Age
Aged
Anemia
Anemia - virology
Asymptomatic
Biomedical research
Blood
Blood platelets
Coronaviruses
COVID-19
COVID-19 - blood
COVID-19 - complications
Female
Females
Gender
Hematology
Hospital patients
Hospitalization
Hospitals
Humans
Leukopenia
Leukopenia - virology
Lymphocyte Count
Lymphocytes
Male
Medical examination
Medical laboratories
Middle Aged
Mortality
Neutrophils
Pandemics
Parameters
Patients
Physicians
Retrospective Studies
Saudi Arabia
Severe acute respiratory syndrome coronavirus 2
Statistics
Thrombocytopenia
Thrombocytopenia - virology
Viral diseases
Saudi Arabia
ISSN:2314-6133, 2314-6141, 2314-6141
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:COVID-19 is a global pandemic viral infection that has affected millions worldwide. Limited data is available on the effect of COVID-19 on hematological parameters in Saudi Arabia. This study is aimed at examining the role of hematological parameters among COVID-19 patients admitted to King Khalid Hospital in Najran, Saudi Arabia. This is a retrospective, hospital-based study of 514 cases who were recruited during August to October 2020. 257 COVID-19 patients formed the study group, and a further 257 negative subjects formed the control group. Anemia was significantly elevated in positive subjects over controls (respectively, 64.2% and 35.8%), with patients 2.5 times more likely to be anemic (p<0.01). Thrombocytopenia was higher in patients over controls (respectively, 62% and 38%), with patients ~1.7 times more likely to be thrombocytopenic (p<0.01). Moreover, leukopenia was significantly higher in patients over controls (respectively, 71% and 29%), with positive subjects ~2.6 times more likely to be leukopenic. Our study results indicate that mild anemia associated with leukopenia may have diagnostic value for COVID-19. Careful assessment of hematological parameters, at baseline and throughout the disease path, will assist physicians in formulating personalized approaches to treatment and promptly offer intensive care to those in greater need.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Correction/Retraction-4
ObjectType-Undefined-3
Academic Editor: Yuvaraja Teekaraman
ISSN:2314-6133
2314-6141
2314-6141
DOI:10.1155/2022/4620037